vs

Side-by-side financial comparison of Cellectis S.A. (CLLS) and GREENPOWER MOTOR Co INC. (GP). Click either name above to swap in a different company.

Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $7.2M, roughly 1.3× GREENPOWER MOTOR Co INC.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -265.9%, a 200.2% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs -11.5%).

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

CLLS vs GP — Head-to-Head

Bigger by revenue
CLLS
CLLS
1.3× larger
CLLS
$9.5M
$7.2M
GP
Growing faster (revenue YoY)
CLLS
CLLS
+386.5% gap
CLLS
375.0%
-11.5%
GP
Higher net margin
GP
GP
200.2% more per $
GP
-65.6%
-265.9%
CLLS

Income Statement — Q2 FY2024 vs Q3 FY2025

Metric
CLLS
CLLS
GP
GP
Revenue
$9.5M
$7.2M
Net Profit
$-25.3M
$-4.7M
Gross Margin
14.6%
Operating Margin
-181.1%
Net Margin
-265.9%
-65.6%
Revenue YoY
375.0%
-11.5%
Net Profit YoY
-51.9%
-2.1%
EPS (diluted)
$-0.28
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLLS
CLLS
GP
GP
Q4 24
$7.2M
Q3 24
$5.3M
Q2 24
$9.5M
$3.0M
Q4 23
$8.2M
Q3 23
$1.6M
$8.4M
Q2 23
$2.0M
$17.6M
Q4 22
$12.8M
Q2 22
$2.7M
Net Profit
CLLS
CLLS
GP
GP
Q4 24
$-4.7M
Q3 24
$-4.7M
Q2 24
$-25.3M
$-5.4M
Q4 23
$-4.6M
Q3 23
$-17.5M
$-4.3M
Q2 23
$-16.6M
$-2.8M
Q4 22
$-3.4M
Q2 22
$-19.5M
Gross Margin
CLLS
CLLS
GP
GP
Q4 24
14.6%
Q3 24
8.6%
Q2 24
7.4%
Q4 23
16.6%
Q3 23
14.6%
Q2 23
97.3%
15.9%
Q4 22
17.4%
Q2 22
87.9%
Operating Margin
CLLS
CLLS
GP
GP
Q4 24
Q3 24
Q2 24
-181.1%
Q4 23
Q3 23
-1258.1%
Q2 23
-1180.5%
Q4 22
Q2 22
-1003.0%
Net Margin
CLLS
CLLS
GP
GP
Q4 24
-65.6%
Q3 24
-87.9%
Q2 24
-265.9%
-179.8%
Q4 23
-56.9%
Q3 23
-1064.1%
-50.4%
Q2 23
-831.6%
-16.0%
Q4 22
-26.4%
Q2 22
-714.4%
EPS (diluted)
CLLS
CLLS
GP
GP
Q4 24
$-0.17
Q3 24
$-0.18
Q2 24
$-0.28
$-0.21
Q4 23
$-0.19
Q3 23
$-0.31
$-0.17
Q2 23
$-0.20
$-0.11
Q4 22
$-0.14
Q2 22
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLLS
CLLS
GP
GP
Cash + ST InvestmentsLiquidity on hand
$149.0M
$621.1K
Total DebtLower is stronger
Stockholders' EquityBook value
$148.6M
$2.1M
Total Assets
$407.1M
$37.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLLS
CLLS
GP
GP
Q4 24
$621.1K
Q3 24
$116.9K
Q2 24
$149.0M
$528.3K
Q4 23
$4.0M
Q3 23
$2.0M
Q2 23
$84.4M
$1.5M
Q4 22
$609.6K
Q2 22
$129.4M
Stockholders' Equity
CLLS
CLLS
GP
GP
Q4 24
$2.1M
Q3 24
$4.2M
Q2 24
$148.6M
$8.6M
Q4 23
$18.1M
Q3 23
$76.1M
$22.3M
Q2 23
$96.6M
$26.2M
Q4 22
$27.3M
Q2 22
$180.5M
Total Assets
CLLS
CLLS
GP
GP
Q4 24
$37.4M
Q3 24
$39.4M
Q2 24
$407.1M
$43.5M
Q4 23
$50.2M
Q3 23
$209.7M
Q2 23
$227.7M
Q4 22
Q2 22
$320.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLLS
CLLS
GP
GP
Operating Cash FlowLast quarter
$28.9M
$-1.1M
Free Cash FlowOCF − Capex
$27.6M
FCF MarginFCF / Revenue
290.5%
Capex IntensityCapex / Revenue
13.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLLS
CLLS
GP
GP
Q4 24
$-1.1M
Q3 24
$-1.3M
Q2 24
$28.9M
$-3.2M
Q4 23
$1.4M
Q3 23
$-5.4M
Q2 23
$-47.4M
$7.8M
Q4 22
Q2 22
$-60.2M
Free Cash Flow
CLLS
CLLS
GP
GP
Q4 24
Q3 24
Q2 24
$27.6M
Q4 23
Q3 23
Q2 23
$-47.9M
Q4 22
Q2 22
$-61.7M
FCF Margin
CLLS
CLLS
GP
GP
Q4 24
Q3 24
Q2 24
290.5%
Q4 23
Q3 23
Q2 23
-2391.4%
Q4 22
Q2 22
-2266.7%
Capex Intensity
CLLS
CLLS
GP
GP
Q4 24
Q3 24
Q2 24
13.2%
Q4 23
Q3 23
Q2 23
24.1%
Q4 22
Q2 22
56.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons